Search results for "Antivirals"
Best practices for HCV care include less invasive testing for many patients, says ACP
The College's new advice on treating hepatitis C virus (HCV) identifies patients who can be safely treated in primary care with laboratory monitoring limited to the beginning and end of treatment and no invasive testing.
https://immattersacp.org/weekly/archives/2020/10/06/4.htm
6 Oct 2020
News on booster doses and omicron, COVID-19 and women's health, outpatient treatments
Recipients of mRNA COVID-19 vaccines are now eligible for boosters at five months, the CDC released additional data on vaccine safety in pregnancy, a study found a short-term association between COVID-19 vaccination and menstrual changes, and new outpatient treatments were authorized.
https://immattersacp.org/weekly/archives/2022/01/11/1.htm
11 Jan 2022
MKSAP Quiz: 4 days of fever and arthralgia
A 43-year-old man is evaluated for 4 days of fever and arthralgia, as well as a raised purple rash over his lower extremities of 1 week's duration. He is a current intravenous drug user. He has no other medical problems and takes no medications. Following a physical exam, lab studies, and skin findings, what is the most appropriate treatment?
https://immattersacp.org/archives/2019/05/mksap-quiz-4-days-of-fever-and-arthralgia.htm
1 May 2019
New research analyzes COVID-19 outcomes, testing, and experimental treatments
A retrospective report looked at serologic antibody testing, while two case series reports described use of convalescent plasma in critically ill patients with COVID-19 in China.
https://immattersacp.org/weekly/archives/2020/04/07/2.htm
7 Apr 2020
Warning on using hep C drugs with amiodarone
This update covers combining amiodarone, sofosbuvir, and another direct-acting antiviral for hepatitis C, as well as the approval of a non-invasive test to aid in the diagnosis of gastroparesis.
https://immattersacp.org/archives/2015/06/fda.htm
1 Jun 2015
IDSA offers criteria on testing for COVID-19; new research looks at clots, treatments
The Infectious Diseases Society of America (IDSA) released guidance for COVID-19 testing among inpatients and outpatients, while studies offered further support for anticoagulation but showed no benefit from hydroxychloroquine or lopinavir-ritonavir.
https://immattersacp.org/weekly/archives/2020/05/12/1.htm
12 May 2020
Latest updates on ACP's priorities, initiatives
ACP Spotlight offers readers a look at ACP's current top priorities and initiatives, as well as highlights from our e-newsletter, ACP Internist Weekly.
https://immattersacp.org/archives/2020/04/latest-updates-on-acps-priorities-initiatives.htm
1 Apr 2020
CDC issues interim guidance on evaluation, treatment of suspected vaping injuries
The evaluation of patients with suspected e-cigarette, or vaping, product use-associated lung injury (EVALI) should include pulse oximetry, chest X-ray, and, in some cases, chest CT, the CDC advised.
https://immattersacp.org/weekly/archives/2019/10/22/2.htm
22 Oct 2019
Updated hearing loss guideline clarifies timing of interventions, changes terminology
For sudden hearing loss, urgent evaluation and initiation of treatment are important, according to a guideline update from the American Academy of Otolaryngology–Head and Neck Surgery.
https://immattersacp.org/weekly/archives/2019/08/13/4.htm
13 Aug 2019
Spotting syphilis, other STIs in the internist's office
Some patients need more than just routine screening for sexually transmitted infections (STIs). Accurate diagnosis and timely treatment can improve quality of life while preventing re-infection.
https://immattersacp.org/archives/2016/07/STIs.htm
1 Jul 2016